Genexa Senna Laxative
NDC Package 69676-0050-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Genexa Senna Laxative is usesrelieves occasional constipation (irregularity)generally produces bowel movement in 6 to 12 hours. Marketed by Genexa Inc., this product is identified by NDC 69676-0050 and is authorized under FDA application part334.

Identification & Billing

NDC Package Code
69676-0050-5
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET in 1 BOTTLE, PLASTIC
Product Code
69676-0050
11-Digit Billing Format
69676005005
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Genexa Senna Laxative
Dosage Form
-
Usage Information
Usesrelieves occasional constipation (irregularity)generally produces bowel movement in 6 to 12 hours

Regulatory & Marketing

Labeler Name
Genexa Inc.
FDA Application #
part334
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
10-20-2020
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69676-0050-5 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet in 1 bottle, plastic of Genexa Senna Laxative, labeled by Genexa Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Genexa Inc. on October 20, 2020. The current certification is valid through December 31, 2024.

How is this Genexa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69676005005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69676-0050-5
11-Digit CMS (5-4-2)
69676-0050-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.